本页面由Tiger Trade Technology Pte. Ltd.提供服务

Cartesian Therapeutics

6.57
-0.4200-6.01%
盘后:6.570.00000.00%19:30 EDT
成交量:21.86万
成交额:144.60万
市值:1.99亿
市盈率:-1.13
高:7.02
开:6.98
低:6.57
收:6.99
52周最高:11.00
52周最低:5.60
股本:3,025.54万
流通股本:1,240.27万
量比:1.57
换手率:1.76%
股息:- -
股息率:- -
每股收益(TTM):-5.7983
每股收益(LYR):-5.0200
净资产收益率:-7029.26%
总资产收益率:-17.43%
市净率:-1.59
市盈率(LYR):-1.31

数据加载中...

2024/11/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/07

重要事件披露

Form 8-K - Current report
2024/10/15

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/10/04

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/09/28

SEC问询函

Form CORRESP - Correspondence
2024/09/27

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/09/26

重要事件披露

Form 8-K - Current report
2024/09/23

重要事件披露

Form 8-K - Current report
2024/09/21

SEC问询函

Form CORRESP - Correspondence
2024/09/20

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/09/10

SEC问询函

Form CORRESP - Correspondence
2024/09/09

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/08/08

重要事件披露

Form 8-K - Current report
2024/08/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/02

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/07/12

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/07/05

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/07/02

重要事件披露

Form 8-K - Current report
2024/06/17

重要事件披露

Form 8-K - Current report
2024/05/22

重要事件披露

Form 8-K - Current report